Acadia Healthcare (NASDAQ:ACHC) Stock Price Down 5.1% – Here’s What Happened

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) traded down 5.1% during trading on Tuesday. The stock traded as low as $29.78 and last traded at $29.7540. Approximately 762,978 shares were traded during trading, a decline of 73% from the average daily volume of 2,825,651 shares. The stock had previously closed at $31.34.

Wall Street Analyst Weigh In

Several research firms recently commented on ACHC. TD Cowen raised their price target on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Leerink Partners increased their target price on Acadia Healthcare from $30.00 to $33.00 and gave the company a “market perform” rating in a research note on Wednesday, September 23rd. Barclays raised their target price on Acadia Healthcare from $25.00 to $32.00 and gave the company an “equal weight” rating in a report on Thursday, July 30th. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a research report on Wednesday, September 9th. Finally, Raymond James Financial cut Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $39.00 price target for the company. in a report on Monday, September 28th. Eight equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, Acadia Healthcare has an average rating of “Hold” and an average price target of $30.69.

Acadia Healthcare Stock Down 6.1%

The stock has a market capitalization of $2.74 billion, a P/E ratio of -2.37, a P/E/G ratio of 10.15 and a beta of 0.63. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.20. The stock’s 50 day simple moving average is $28.94 and its 200 day simple moving average is $25.31.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.03. The company had revenue of $865.84 million during the quarter, compared to the consensus estimate of $844.19 million. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The company’s revenue was down .4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.83 EPS. As a group, research analysts predict that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current fiscal year.

Hedge Funds Weigh In On Acadia Healthcare

A number of hedge funds have recently bought and sold shares of ACHC. Allworth Financial LP bought a new stake in Acadia Healthcare in the second quarter valued at about $45,000. Global Retirement Partners LLC acquired a new stake in Acadia Healthcare during the second quarter valued at approximately $68,000. Integrated Wealth Concepts LLC bought a new position in Acadia Healthcare during the 2nd quarter worth approximately $79,000. Quantbot Technologies LP bought a new position in Acadia Healthcare during the 2nd quarter worth approximately $88,000. Finally, Public Employees Retirement System of Ohio acquired a new position in shares of Acadia Healthcare in the 2nd quarter worth approximately $144,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.

Acadia’s services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.

Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.